Q3 2023 Holdings
Filed 2023-11-14 | 128 holdings | $4.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.0M | 2,718,735 | 7.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $174.6M | 3,306,800 | 3.7% |
| Humana Inc(HUM) | COM | 444859102 | $166.6M | 342,500 | 3.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $145.9M | 499,000 | 3.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $143.1M | 556,800 | 3.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $142.9M | 1,615,210 | 3.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $122.9M | 8,998,338 | 2.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $108.6M | 1,055,000 | 2.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $106.6M | 2,269,637 | 2.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $99.9M | 186,000 | 2.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $98.4M | 2,169,500 | 2.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $91.8M | 3,968,588 | 1.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $90.8M | 401,900 | 1.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $86.1M | 2,896,074 | 1.8% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $85.3M | 1,959,050 | 1.8% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $84.5M | 2,239,900 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $83.5M | 14,567,176 | 1.8% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $80.7M | 1,224,400 | 1.7% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $80.4M | 73,114,592 | 1.7% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $78.8M | 2,895,632 | 1.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $73.5M | 269,000 | 1.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $72.8M | 143,800 | 1.5% |
| Apollomics Inc | CL A SHS | G0411D107 | $67.4M | 17,993,635 | 1.4% |
| The Cigna Group(CI) | COM | 125523100 | $66.2M | 231,500 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $64.1M | 529,200 | 1.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $61.6M | 3,777,778 | 1.3% |
| Rayzebio Inc | COM | 75525N107 | $58.2M | 2,622,909 | 1.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $57.5M | 165,400 | 1.2% |
| Acelyrin Inc | COM | 00445A100 | $54.2M | 5,326,302 | 1.2% |
| R1 RCM Inc(RCM1USD) | COM | 77634L105 | $51.9M | 3,441,000 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $51.3M | 1,007,148 | 1.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $49.2M | 330,000 | 1.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $48.7M | 2,292,531 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $48.3M | 1,514,734 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $47.9M | 1,260,500 | 1.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $47.6M | 17,713,600 | 1.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $46.8M | 415,900 | 1.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $46.7M | 4,081,592 | 1.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $45.1M | 12,048,773 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $44.1M | 22,362,850 | 0.9% |
| Natera Inc(NTRA) | COM | 632307104 | $40.7M | 920,581 | 0.9% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $40.3M | 6,563,077 | 0.9% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $40.1M | 3,322,488 | 0.9% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $39.6M | 5,559,528 | 0.8% |
| Neuropace Inc(NPCE) | COM | 641288105 | $39.0M | 4,012,281 | 0.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $38.3M | 7,619,135 | 0.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $37.0M | 253,309 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $36.9M | 5,779,071 | 0.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $35.3M | 70,000 | 0.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $34.9M | 9,240,887 | 0.7% |